Skip to main content
OpenTrials

Clinical trial condition

Dermatitis, Atopic

Explore clinical trials studying Dermatitis, Atopic. Study availability and eligibility vary by location and protocol.

152 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Dermatitis, Atopic trial results

Completed

A Study to Assess Immunization Responses in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Treated With Nemolizumab

NCT04365387

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +13 more
Locations
  • Galderma Investigational Site (Site#9922) Phoenix, Arizona, United States
  • Galderma Investigational Site (Site#8873) Scottsdale, Arizona, United States
  • Galderma Investigational Site (Site#8447) Fort Smith, Arkansas, United States
  • Galderma Investigational Site (Site#8831) Anaheim, California, United States
View all 64 locations
View Trial Details
Completed

Evaluation of 611(Recombinant Humanized Anti-interleukin-4 Receptor Alpha IgG4 Monoclonal Antibody) in Chinese Adults With Moderate to Severe Atopic Dermatitis

NCT06173284

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +8 more
Locations
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • Dermatology Hospital of Jiangxi Province Nanchang, Jiangxi, China
  • Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China
  • The Fourth Affiliated Hospital Zhejiang University School of Medicine Jinhua, Zhejiang, China
View Trial Details
Completed

Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

NCT03422822

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
Locations
  • Total Skin and Beauty Dermatology Center, PC Birmingham, Alabama, United States
  • Clinical Research Center of Alabama, LLC Birmingham, Alabama, United States
  • University of Alabama at Birmingham - Dermatology Research Clinic Birmingham, Alabama, United States
  • University of Alabama at Birmingham Hospital Outreach Lab Birmingham, Alabama, United States
View all 539 locations
View Trial Details
Completed

To Assess the Efficacy and Safety of SCD-044 in the Treatment of Moderate to Severe Atopic Dermatitis

NCT04684485

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +8 more
Locations
  • Omni Dermatology Phoenix, Arizona, United States
  • Yuma Clinical Trials, LLC Yuma, Arizona, United States
  • T. Joseph Raoof Md, Imc./Encino Research Center Encino, California, United States
  • Metropolis Dermatology Los Angeles, California, United States
View all 58 locations
View Trial Details
Completed

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986326 in Participants With Atopic Dermatitis

NCT06248814

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
Locations
  • Local Institution - 0004 Prague, PR, Czechia
  • Local Institution - 0009 Pardubice, Czechia
  • Local Institution - 0006 Clermont-Ferrand, France
  • Local Institution - 0010 Nice, France
View all 13 locations
View Trial Details
Completed

A Study in Patients With Atopic Eczema to Test How Effective BI 655130 is and How Well it is Tolerated

NCT03822832

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +8 more
Locations
  • Center for Dermatology and Plastic Surgery Scottsdale, Arizona, United States
  • Clinical Physiology Associates Fort Myers, Florida, United States
  • Finlay Medical Research Corp Miami, Florida, United States
  • University of South Florida Tampa, Florida, United States
View all 23 locations
View Trial Details
Completed

Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis

NCT04975438

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +8 more
Locations
  • GSK Investigational Site North Little Rock, Arkansas, United States
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Tampa, Florida, United States
  • GSK Investigational Site Troy, Michigan, United States
View Trial Details
Completed

Multiple Rising Dose Study of MK-6194 in Participants With Atopic Dermatitis (MK-6194-008)

NCT05450198

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +8 more
Locations
  • Arkansas Research Trials-Clinical Trials ( Site 0002) North Little Rock, Arkansas, United States
  • Miami Dermatology and Laser Research ( Site 0025) Miami, Florida, United States
  • Global Health Research Center, Inc. ( Site 0005) Miami Lakes, Florida, United States
  • Genesis Clinical Research, LLC ( Site 0004) Tampa, Florida, United States
View all 19 locations
View Trial Details

Related conditions